et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofaa446 (Peer Reviewed)
Small RCT on very late stage use of HC
Q, with 48% on oxygen at baseline. 67 HC
Q patients, 61 control.
Baseline states were not comparable - 82% more HC
Q patients had the highest severity at baseline, there was 32% more male HC
Q patients, and 44% more control patients used AZ. The HC
Q group also had significantly more patients with cerebrovascular disease, cardiovascular disease (non-hypertension), renal disease (non-dialysis), and a history of organ transplants.
30 day mortality RR 1.06, p
death, ↑6.0%, p=1.00